METTL3 and esophageal squamous cell carcinoma: For instance, METTL3 acts as a promoter of ferroptosis in esophageal squamous cell carcinoma (ESCC) (Wang et al., 2021), while WTAP suppresses ferroptosis in hepatocellular carcinoma (HCC) (Li et al., 2024).